Thyroid Eye Disease (TED) is an autoimmune condition (a condition where the immune system attacks its own body tissues) most commonly related to overproduction of the thyroid hormones (hyperthyroidism). This condition causes pain, redness, and swelling in the tissues in and around the eyes, leading to bulging of eyes (proptosis), double vision (diplopia), reduced movement of one or both eyes (restricted duction and version), and increased pressure on the nerves in the eyes, eventually followed by loss of vision.The purpose of the study is to see if the study drug, VRDN-001, is safe and tolerable (the body reacts acceptably to study drug) in participants with TED when administered as a series of 5 intravenous (IV) infusions (receiving study drug through a needle or catheter slowly over a period of time). The study will also look at how the study treatment impacts the signs and symptoms of TED.
CONTACT US ABOUT TED TRIAL